Next 10 |
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-21 10:00:00 ET Summary Hims & Hers Health has fallen below $20 after initial excitement over a compounded GLP-1 drug solution wanes. The health and wellness platform offers a compounded semaglutide drug at lower prices due to shortage of name-brand drugs. A short r...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...
2024-07-19 09:35:38 ET Summary Hims & Hers Health, Inc. has scaled the company's unique medicine & health ecommerce platform incredibly well through new product launches and excessive marketing. The company's generic medicine offering comes with a low moat, making Hims &am...
2024-07-18 17:34:23 ET Summary Hims & Hers is dedicated to telehealth and provides healthcare services remotely. It has an asset-light business model that has had extraordinary growth. The company began its growth by attacking markets sometimes overlooked by traditional medici...
2024-07-16 07:00:00 ET Summary Small-cap stocks struggled in the first half of 2024 due to economic concerns and higher interest rates, lagging behind broader market indexes. The outlook for small caps in the second half depends on timely interest rate cuts and stable economic gro...
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...
2024-07-02 13:00:00 ET Summary 21 new analysts joined in June and are highlighted today. Each is introduced with some details on their first investment thesis on Seeking Alpha and their background. Analysts cover a range of sectors including biotech, technology, consumer staples, ...
2024-07-02 11:50:00 ET There are just a little more than 30 U.S. exchange-listed companies with market caps greater than $1 billion that more than doubled in the first half of this year. It's fair to say that most of them won't repeat the feat through the final six months of 2024. It doesn'...
2024-06-29 10:00:00 ET Shares of Hims & Hers (NYSE: HIMS) fell on Thursday after a short report was published by a short-seller. This kind of report can often send stocks lower, but is it a reason to panic or a buying opportunity? In this video, Travis Hoium digs into the report...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...